ARWR - Arrowhead Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARWR is currently covered by 15 analysts with an average price target of $39.03. This is a potential upside of $20.43 (109.84%) from yesterday's end of day stock price of $18.6.

Arrowhead Pharmaceuticals's activity chart (see below) currently has 166 price targets and 170 ratings on display. The stock rating distribution of ARWR is 12.96% HOLD and 87.04% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.21% with an average time for these price targets to be met of 252.16 days.

Highest price target for ARWR is $62, Lowest price target is $27, average price target is $39.03.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 11-Oct-2024. First documented stock forecast 05-Mar-2014.

Currently out of the existing stock ratings of ARWR, 7 are a HOLD (12.96%), 47 are a BUY (87.04%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$60

$41.43 (223.10%)

$60

1 months 9 days ago
(11-Oct-2024)

0/18 (0%)

$41.56 (225.38%)

Buy

$62

$43.43 (233.87%)

$59

1 months 12 days ago
(08-Oct-2024)

22/35 (62.86%)

$43.98 (244.06%)

154

Buy

$42

$23.43 (126.17%)

$50

1 months 25 days ago
(26-Sep-2024)

2/9 (22.22%)

$22.38 (114.07%)

100

Buy

$55

$36.43 (196.18%)

$55

3 months 8 days ago
(12-Aug-2024)

8/15 (53.33%)

$32.06 (139.76%)

135

Buy

$60

$41.43 (223.10%)

$60

4 months 3 days ago
(17-Jul-2024)

4/16 (25%)

$31.98 (114.13%)

193

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?

On average it took 252.16 days on average for the stock forecasts to be realized with a an average price target met ratio 67.21

Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?

LUCA ISSI

Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?

Luca Issi works at RBC and has 8 price targets and 5 ratings on ARWR

Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?

Esther Rajavelu with highest potential upside - $75.13

Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?

Alethia Young with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?